Greenwood Capital Associates LLC Pfizer Inc Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Pfizer Inc stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 50,899 shares of PFE stock, worth $1.36 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

50,899

Holding current value

$1.36 Million

% of portfolio

0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$27.7 - $31.39 $1.41 Million - $1.6 Million	50,899 New	50,899 $1.47 Million
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $4.56 Million - $5.24 Million	-176,105 Reduced 95.23%	8,821 $244,000
Q4 2023 Mar 05, 2024	BUY	$26.13 - $33.94 $309,718 - $402,290	11,853 Added 6.85%	184,926 $5.32 Million
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $912,318 - $1.07 Million	-28,430 Reduced 14.11%	173,073 $5.74 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $763,865 - $883,774	21,148 Added 11.73%	201,503 $7.39 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $234,882 - $305,782	-5,963 Reduced 3.2%	180,355 $7.36 Million
Q4 2022 Jan 26, 2023	SELL	$41.75 - $54.5 $1.49 Million - $1.94 Million	-35,666 Reduced 16.07%	186,318 $0
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $1.06 Million - $1.3 Million	-24,276 Reduced 9.86%	221,984 $9.71 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $11.4 Million - $13.6 Million	245,708 Added 44512.32%	246,260 $12.9 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $10.3 Million - $12.8 Million	-226,192 Reduced 99.76%	552 $29,000
Q4 2021 Feb 03, 2022	SELL	$41.32 - $61.25 $430,265 - $637,796	-10,413 Reduced 4.39%	226,744 $13.4 Million
Q3 2021 Oct 27, 2021	BUY	$39.25 - $50.42 $3.01 Million - $3.86 Million	76,579 Added 47.69%	237,157 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $193,267 - $218,939	5,382 Added 3.47%	160,578 $6.29 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $2.05 Million - $2.31 Million	-61,205 Reduced 28.28%	155,196 $5.62 Million
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $2.88 Million - $3.67 Million	-86,126 Reduced 28.47%	216,401 $7.97 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $368,681 - $432,547	11,612 Added 3.99%	302,527 $11.1 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $51,836 - $62,885	-1,721 Reduced 0.59%	290,915 $9.51 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $196,102 - $280,188	-7,255 Reduced 2.42%	292,636 $9.55 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $204,663 - $232,267	6,217 Added 2.12%	299,891 $11.1 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $2.47 Million - $3.2 Million	75,976 Added 34.9%	293,674 $10.6 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $115,761 - $150,109	-3,563 Reduced 1.61%	217,698 $9.43 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $332,820 - $373,680	9,000 Added 4.24%	221,261 $9.59 Million
Q1 2019 May 03, 2019	BUY	$37.5 - $41.2 $157,912 - $173,493	4,211 Added 2.02%	212,261 $9.02 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $1.7 Million - $1.94 Million	44,242 Added 27.01%	208,050 $9.08 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $170,729 - $207,084	-4,953 Reduced 2.93%	163,808 $7.22 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $88,122 - $93,947	2,672 Added 1.61%	168,761 $6.12 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $53,002 - $61,490	1,661 Added 1.01%	166,089 $5.9 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $82,917 - $87,977	-2,493 Reduced 1.49%	164,428 $5.96 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $5.17 Million - $5.7 Million	166,921	166,921 $5.96 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account

Greenwood Capital Associates LLC Pfizer Inc Transaction History